Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis - PubMed (original) (raw)
Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis
Ying-Ying Yang et al. J Hepatol. 2008 Jul.
Abstract
Background/aims: Increased intrahepatic resistance (IHR) in cirrhosis is due to fibrosis and hepatic endothelial dysfunction (HED). Besides producing fibrosis, increased reactive oxygen species (ROS) promotes ROS-related nitration of anti-oxidative enzymes in cirrhotic livers. Tyrosine nitration (nitrotyrosilation)-related inactivation of anti-oxidative enzymes is increased in cirrhotic livers. This study investigates effects of N-acetylcysteine (NAC) administrations in bile-duct-ligation (BDL) rats.
Methods: This study measured portal venous pressure (PVP), IHR, hepatic endothelial function, hepatic levels of anti-oxidants and oxidants, type III procollagen (PIIIP), proteins expression of thromboxane synthase (TXS), nitrotyrosine, manganese superoxide dismutase (MnSOD), and hepatic NOx and thromboxane A(2) (TXA(2)) production in perfusates.
Results: The improvement of HED was associated with decreased PVP and IHR, hepatic protein and mRNA levels of PIIIP, protein expression of TXS and nitrotyrosine, oxidants and production of TXA(2) in NAC-treated BDL rat livers. Conversely, hepatic NOx production, anti-oxidants, and protein expression of MnSOD were increased in NAC-treated BDL rat livers.
Conclusions: In NAC-treated cirrhotic rats, the decrease in IHR was mainly caused by its anti-oxidative effect-related prevention of hepatic fibrogenesis associated with the decrease of oxidants-related nitrotyrosilation and improvement of HED.
Similar articles
- Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY, Huang YT, Lee KC, Lee FY, Lee TY, Hou MC, Lin HC, Lee SD. Yang YY, et al. Clin Sci (Lond). 2009 Jan;116(1):71-9. doi: 10.1042/CS20080075. Clin Sci (Lond). 2009. PMID: 18479249 - Thalidomide decreases intrahepatic resistance in cirrhotic rats.
Yang YY, Huang YT, Lin HC, Lee FY, Lee KC, Chau GY, Loong CC, Lai CR, Lee SD. Yang YY, et al. Biochem Biophys Res Commun. 2009 Mar 13;380(3):666-72. doi: 10.1016/j.bbrc.2009.01.160. Epub 2009 Jan 31. Biochem Biophys Res Commun. 2009. PMID: 19285019 - The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
Lin HC, Yang YY, Tsai TH, Huang CM, Huang YT, Lee FY, Liu TT, Lee SD. Lin HC, et al. J Hepatol. 2011 Jun;54(6):1145-53. doi: 10.1016/j.jhep.2010.09.026. Epub 2010 Nov 12. J Hepatol. 2011. PMID: 21145843 - Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
Lee KC, Yang YY, Huang YT, Lee FY, Hou MC, Lin HC, Lee SD. Lee KC, et al. Clin Sci (Lond). 2010 Apr 7;119(1):45-55. doi: 10.1042/CS20090601. Clin Sci (Lond). 2010. PMID: 20132096 - Alteration of intrahepatic microcirculation in cirrhotic livers.
Yang YY, Lin HC. Yang YY, et al. J Chin Med Assoc. 2015 Aug;78(8):430-7. doi: 10.1016/j.jcma.2015.05.005. J Chin Med Assoc. 2015. PMID: 26074366 Review.
Cited by
- Advances in the Study of the Potential Hepatotoxic Components and Mechanism of Polygonum multiflorum.
Yu HS, Wang LL, He Y, Han LF, Ding H, Song XB, Gao XM, Yun NR, Li Z. Yu HS, et al. Evid Based Complement Alternat Med. 2020 Sep 30;2020:6489648. doi: 10.1155/2020/6489648. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33062019 Free PMC article. Review. - Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.
Shearn CT, Fennimore B, Orlicky DJ, Gao YR, Saba LM, Battista KD, Aivazidis S, Assiri M, Harris PS, Michel C, Merrill GF, Schmidt EE, Colgan SP, Petersen DR. Shearn CT, et al. Free Radic Biol Med. 2019 Nov 1;143:101-114. doi: 10.1016/j.freeradbiomed.2019.07.036. Epub 2019 Aug 1. Free Radic Biol Med. 2019. PMID: 31377417 Free PMC article. - Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
Zhang J, Guo X, Hamada T, Yokoyama S, Nakamura Y, Zheng J, Kurose N, Ishigaki Y, Uramoto H, Tanimoto A, Yamada S. Zhang J, et al. Int J Mol Sci. 2018 Aug 24;19(9):2509. doi: 10.3390/ijms19092509. Int J Mol Sci. 2018. PMID: 30149550 Free PMC article. - N-Acetylcysteine Reverses Anxiety and Oxidative Damage Induced by Unpredictable Chronic Stress in Zebrafish.
Mocelin R, Marcon M, D'ambros S, Mattos J, Sachett A, Siebel AM, Herrmann AP, Piato A. Mocelin R, et al. Mol Neurobiol. 2019 Feb;56(2):1188-1195. doi: 10.1007/s12035-018-1165-y. Epub 2018 Jun 6. Mol Neurobiol. 2019. PMID: 29876880 - N-acetyl-L-cysteine increases MnSOD activity and enhances the recruitment of quiescent human fibroblasts to the proliferation cycle during wound healing.
Mao G, Goswami M, Kalen AL, Goswami PC, Sarsour EH. Mao G, et al. Mol Biol Rep. 2016 Jan;43(1):31-9. doi: 10.1007/s11033-015-3935-1. Epub 2015 Dec 15. Mol Biol Rep. 2016. PMID: 26671656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources